Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe.

BMJ · 2010 · PMC2806633 · PMID 20068257

Europe PMC DOI

hedged sentences

0.0600

closest p · 1.2× alpha

0.0700

boldest claim

The sentences

borderline significantP=0.06so close (0.05 < p ≤ 0.1)

Significant interaction terms were route (P=0.03) and calcium (P=0.04), and borderline significant interaction terms were bisphosphonate use (P=0.06) and interval (daily v non-daily, P=0.12).

also in 6,767 other papers

of borderline significanceP=0.07so close (0.05 < p ≤ 0.1)

Bisphosphonate use was of borderline significance (P=0.07).

also in 1,677 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.